Protocol Amendments: Understanding the True Cost and Impact
With 76% of Phase I-IV trials now requiring amendments--up from 57% in 2015--protocol changes have become one of the most…
Dose Optimization: A Strategic Lever in Oncology Drug…
The FDA's Project Optimus has reformed dose optimization and selection requirements. Sponsors who understand the new framework are seeing more…
Modernizing in vivo Study Management: Climb™. The Flexible,…
See how Climb simplifies early-stage in vivo research by unifying experiment design, animal scheduling, and data capture in one platform.…
Unlock Access to Hard-to-Reach Primary Care Clinicians
Pri-Med offers solutions that bridge the gap between your pharma clients’ teams and hard-to-see clinicians. As the healthcare landscape evolves,…
Partnering With Metabolon
Leverage the largest metabolite library to advance your study objectives. Strategic Research Partners We partner with the world’s largest research…
Successful Multichannel Approach Leads to 300% More Monthly…
A long-term investment in your biotech marketing strategy supports long-term growth for your pipeline. Discover how one industry leader achieved…